Xlife Sciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	122	146	279	157	-	-
Market Cap Growth	3.38%	-47.72%	77.76%	-	-	-
Enterprise Value	270	295	434	321	-	-
Last Close Price	21.20	25.40	49.90	29.70	-	-
PE Ratio	4.67	4.26	18.75	10.97	-	-
PS Ratio	145.67	174.69	282.22	152.66	-	-
PB Ratio	0.31	0.37	0.76	0.47	-	-
P/TBV Ratio	2.90	4.04	-	-	-	-
P/FCF Ratio	-	-	1766.87	-	-	-
P/OCF Ratio	-	-	1623.87	-	-	-
EV/Sales Ratio	-	353.76	439.10	311.96	-	-
EV/FCF Ratio	-1127.54	-	2749.02	-	-	-
Debt / Equity Ratio	0.15	0.15	0.16	0.18	0.20	0.40
Debt / FCF Ratio	-	-	359.14	-	-	-
Net Debt / Equity Ratio	0.15	0.15	0.16	0.18	0.19	0.37
Net Debt / EBITDA Ratio	-17.05	-17.46	-12.88	-11.92	-11.83	-15.45
Net Debt / FCF Ratio	-246.72	-136.58	357.75	-13.07	-13.73	-110.55
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Quick Ratio	1.07	1.53	3.11	0.61	1.05	1.60
Current Ratio	1.08	1.54	3.11	0.65	1.06	1.61
Return on Equity (ROE)	6.62%	7.54%	2.64%	2.67%	23.71%	18.56%
Return on Assets (ROA)	-2.33%	-2.30%	-2.53%	-2.70%	-0.98%	-1.14%
Return on Invested Capital (ROIC)	-4.32%	-4.41%	-4.96%	-5.39%	-1.87%	-1.87%
Return on Capital Employed (ROCE)	-3.70%	-3.60%	-4.00%	-4.30%	-1.10%	-1.70%
Earnings Yield	25.15%	23.50%	5.33%	9.12%	-	-
FCF Yield	-0.20%	-0.30%	0.06%	-2.95%	-	-
Buyback Yield / Dilution	20.65%	-1.34%	0.17%	-17.26%	-4.77%	-60.85%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.